securities fraud

Class action filed against Franklin BSP Realty Trust alleges executives made false statements about dividend sustainability between November 2024 and February 2026. Lead plaintiff deadline set for April 27, 2026.

Class action lawsuit filed against $IBRX alleging false statements about Anktiva capabilities and business prospects during January-March 2026.

Class action lawsuit filed against $BSX alleging materially false statements about electrophysiology segment growth. Investors from July 2025-February 2026 may be eligible.

Schall Law Firm investigates PennyMac Financial Services for potential fraud after Q4 2025 earnings triggered 33.3% stock collapse.

Soleno Therapeutics faces securities fraud lawsuit alleging undisclosed DCCR safety risks. Investors must file by May 5, 2026.

Super Micro Computer faces class action lawsuits following DOJ indictment of three individuals for allegedly diverting $2.5B in AI servers to China, causing 33% stock plunge.

ImmunityBio faces securities fraud lawsuit after FDA warns of false cancer cure claims for Anktiva, stock crashes 21% to $7.42.

Trip.com faces securities fraud lawsuit after Chinese antitrust regulators probe alleged monopolistic practices. Stock fell 19.4% in January 2026.

Law firm files class action against Gemini Space Station for allegedly overstating crypto platform viability and financial prospects in IPO disclosures.

$DRVN plummets after disclosing material financial statement errors. Securities lawsuits filed; investors have until May 8 to join class action.

Apollo Global Management faces securities fraud lawsuit over undisclosed Epstein ties. Stock fell 16% during class period; investors have until May 1, 2026 to file.

Schall Law Firm recruits $FCHL investors for securities fraud class action alleging share price manipulation and insider dumping. Deadline: June 16, 2026.

Legal probe launched into $GOCO over alleged illegal kickbacks to brokers (2016-2021). Stock plunged 10.4% following DOJ False Claims Act complaint.

Medical Properties Trust ($MPT) stock plunged 8% after declaring defaults on properties leased to Healthcare Systems of America, triggering a securities fraud investigation.

Pomerantz LLP filed class action against $NKTR over REZOLVE-AA trial failure. Stock dropped 7.77% after December disclosure of ineligible patient enrollment issues.

Pomerantz Law Firm filed securities fraud lawsuit against $AQST after FDA rejected Anaphylm NDA, triggering 37% stock drop. Investor deadline May 4.

Eos Energy stock plummeted 39.44% after missing earnings targets due to production and quality control issues, prompting Pomerantz Law Firm to file securities fraud class action lawsuit.

Pomerantz Law Firm files class action lawsuit against $CORT after FDA rejection of relacorilant causes 50.4% stock decline. Investors urged to act by April 21, 2026 deadline.

Boston Scientific faces class action lawsuit after 17.6% stock drop from weaker-than-expected electrophysiology sales; investors have until May 4, 2026 to join.

Class action lawsuit filed against $SMCI alleges failure to disclose significant Chinese sales violating U.S. export controls and concealing compliance weaknesses.